Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

162.00 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,647
Open 162.00
Bid (Size) 161.50 (1)
Ask (Size) 161.80 (6)
Prev. Close 162.00
Today's Range 162.00 - 162.00
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Is Visa Stock a Buy?
The payments processor enjoys strong growth when the economy is stable, leading to steady stock growth as well. 
Via The Motley Fool
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday
The fallout from the baby powder controversy continues to damage the company. 
Via The Motley Fool

Performance

YTD
-9.09%
-9.09%
1 Month
-9.09%
-9.09%
3 Month
-6.88%
-6.88%
6 Month
-6.85%
-6.85%
1 Year
-5.97%
-5.97%

More News

Read More
These 2 Stocks Led the Dow Lower Monday
Via The Motley Fool
Why Is Johnson & Johnson (JNJ) Stock Down Today?
Via InvestorPlace
J&J Dives After Court Denies Bankruptcy For Litigation-Hamstrung Baby Powder Division
Via Investor's Business Daily
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
Via SBWire
Topics Supply Chain
Exposures Supply Chain
2 of the Best Dividend Stocks to Own in 2023
Via The Motley Fool
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Via The Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
Via Benzinga
3 Dividend Kings to Buy Hand Over Fist in 2023
Via The Motley Fool
2 Blue Chips Under Pressure
Via The Motley Fool
3 Beaten-Down Blue Chip Stocks to Buy Right Now
Via The Motley Fool
3 Low-Risk Dividend Stocks to Buy in 2023
Via The Motley Fool
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Via Investor's Business Daily
The 3 Best Biotech Stocks Under $1 to Buy for January
Via InvestorPlace
3 Warren Buffett Stocks That Could Make You Richer in 2023
Via The Motley Fool
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Via The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear Market
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Via MarketBeat
Topics Economy
Exposures Interest Rates
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
Via Benzinga
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
Via The Motley Fool
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Why Johnson & Johnson Stock Was Stagnant Today
Via The Motley Fool
The Earnings Shall Continue! Today's Key Updates For You
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.